During the past decade, Centro Oncológico de Chihuahua conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Oncológico de Chihuahua" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Parexel" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Centro Oncológico de Chihuahua" are "Carcinoma, Non-Small-Cell Lung" (1 trials), "Chemotherapy-Induced Nausea and Vomiting" (1 trials), "Mesothelioma" (1 trials) and "Non-small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Centro Oncológico de Chihuahua" in a lesser frequency.

Most popular intervention types in "Centro Oncológico de Chihuahua" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Pemetrexed" (2 trials), "Placebo" (2 trials), "Amivantamab" (1 trials), "Carboplatin" (1 trials) and "Cisplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro Oncológico de Chihuahua" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Centro Oncológico de Chihuahua". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Centro Oncológico de Chihuahua, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Centro Oncológico de Chihuahua, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".